Abstract: This invention is directed generally to processes for the preparation of compounds of Formula I: wherein R2, R3, R4, R5, X1, X2, X3, X4, X5, X6 are as defined in the specification.

Abstract: This invention is directed generally to processes for the preparation of compounds of Formula I: wherein R2, R3, R4, R5, X1, X2, X3, X4, X5, X6 are as defined in the specification.

Abstract: Various embodiments of a computer-implemented method, system and computer program product provide a graphical interface. At least one tab is presented on a display. The tab comprises one or more child objects of a parent object of a hierarchy of objects. The tab has a three-dimensional effect. The tab has an apparent bend into the display. The apparent bend into the display increases as a depth of the one or more child objects of the hierarchy increases.

Abstract: A computer implemented method, data processing system, and computer usable code are provided for automatically generating object setup scripts. A form is presented to a user in a graphical user interface. The user provides input in a set of fields within the form, which is received and validated. A set of object setup scripts are then generated based on the user input to the form. To generate the set of object setup scripts based on the user input an analysis is performed on the set of fields as a set of objects, and at least one variable is set to hold the value of the set of objects. String manipulations are used to obtain the values in the set of fields, and the values are entered into the set of object setup scripts.

Abstract: The present invention relates to amidino compounds and salts and prodrugs thereof. In another embodiment the present invention also provides a use of the present compounds in therapy, particular as nitric oxide synthase inhibitors. In a further embodiment, the present invention provides methods of making the amidino compounds.

Abstract: Method of making an alpha-amino acid compound having the structure of Formula 32: comprising treating under hydrolyzing conditions a hydantoin compound having the structure of Formula 33: where the substituents are described herein.

Abstract: A plasma lamp head that has a spherical plasma bulb whose upper hemisphere serves as the top of the head, a decorative face and lower back of the head covering the lower hemisphere of the bulb. Operative components are provide to enable the bulb to illuminate in response to receipt of appropriate energy delivery to excite the plasma within the bulb to illuminate. The face preferably has eyes, a nose, a mouth and ears, any of which may be transparent or translucent so that light shines through when the bulb illuminates. The remainder of the decorative face and lower back of the head may be opaque or translucent material.

Abstract: The present invention relates to amidino compounds and salts and prodrugs thereof. In another embodiment the present invention also provides a use of the present compounds in therapy, particular as nitric oxide synthase inhibitors. In a further embodiment, the present invention provides methods of making the amidino compounds.

Abstract: The present invention relates to amidino compounds and salts and prodrugs thereof. In another embodiment the present invention also provides a use of the present compounds in therapy, particular as nitric oxide synthase inhibitors. In a further embodiment, the present invention provides methods of making the amidino compounds.

Abstract: The present invention relates to amidino compounds and salts and prodrugs thereof. In another embodiment the present invention also provides a use of the present compounds in therapy, particular as nitric oxide synthase inhibitors. In a further embodiment, the present invention provides methods of making the amidino compounds.

Abstract: A method of making an alpha-amino acid compound having the structure of Formula 32: 1

Abstract: A plasma lamp head that has a spherical plasma bulb whose upper hemisphere serves as the top of the head, a decorative face and lower back of the head covering the lower hemisphere of the bulb. Operative components are provide to enable the bulb to illuminate in response to receipt of appropriate energy delivery to excite the plasma within the bulb to illuminate. The face preferably has eyes, a nose, a mouth and ears, any of which may be transparent or translucent so that light shines through when the bulb illuminates. The remainder of the decorative face and lower back of the head may be opaque or translucent material.

Abstract: The present invention relates to amidino compounds and salts and prodrugs thereof. In another embodiment the present invention also provides a use of the present compounds in therapy, particular as nitric oxide synthase inhibitors. In a further embodiment, the present invention provides methods of making the amidino compounds.

Abstract: The present invention relates to amidino compounds and salts and prodrugs thereof. In another embodiment the present invention also provides a use of the present compounds in therapy, particular as nitric oxide synthase inhibitors. In a further embodiment, the present invention provides methods of making the amidino compounds.